Head-to-Head Comparison
OpenEvidence vs UpToDate: Which Is Better for Physicians?
OpenEvidence ranks #2 in our 2026 clinical decision support rankings with a 4.3-star rating from 16 physician reviews, while UpToDate ranks #3 with a 4.1-star rating from 19 reviews. OpenEvidence leads in overall physician satisfaction, though both platforms serve different clinical needs. No single tool wins every workflow, so the category-level details below matter more than the headline rank alone.
Feature Comparison
| Feature | OpenEvidence | UpToDate |
|---|---|---|
| Rating | Very Good | Very Good |
| Category | AI Medical Research Assistant | Clinical Reference & Decision Support |
| Pricing | Free (Ad-Supported) | From $559/year Individual |
| Founded | 2022 | 1992 |
| Headquarters | Miami, FL | Waltham, MA |
| Evidence Citations | Yes | Yes |
| AI Differential Diagnosis | No | No |
| Drug Database | No | Yes |
| Drug Interaction Checker | No | No |
| Medical Calculators | Yes | Yes |
| Natural Language Search | Yes | No |
| Document & Image Upload | No | No |
| EHR Integration | Yes | Yes |
| Mobile App | Yes | Yes |
| Built-in Dialer | Yes | No |
| AI Clinical Scribe | No | No |
| CME Credits | No | Yes |
| Multi-Language | Yes | No |
Strengths & Limitations
OpenEvidence
Strengths
- +Useful for generalist clinical questions — fast, cited answers for everyday practice
- +Widely adopted clinical AI in the US (757K+ physicians)
- +Free for all verified physicians
- +Broadest content partnership network: NEJM, JAMA (all 11 specialty journals), NCCN, ACC, AAFP, ACEP, ADA, AAOS, 300+ journals
- +Native iOS and Android apps with Home Screen widgets
- +Quick Consult and Deep Consult modes for different clinical needs
- +Built-in dialer for calling patients, pharmacies, and colleagues
- +Well-funded with strong investor backing ($12B valuation, $100M annual revenue)
Limitations
- –No differential diagnosis generation or drug dosing tools
- –Ad-supported revenue model (pharmaceutical/healthcare advertising)
- –EHR integration is early-stage (Sutter Health/Epic announced February 2026)
- –Preprint by Jagarapu et al. (2025) reported 41% accuracy on complex subspecialty scenarios
- –Clinical depth narrower than platforms with drug databases and medical calculators
UpToDate
Strengths
- +Large medical knowledge base (12,000+ clinical topics)
- +Rigorous physician-authored and peer-reviewed content (7,400+ authors)
- +GRADE evidence ratings for transparency
- +Used by 2M+ clinicians in 190+ countries (per Wolters Kluwer)
- +Trusted by institutions worldwide for 30+ years
- +CME credits available through use
- +Available on mobile and desktop
- +Regular content updates
Limitations
- –Expensive individual subscription ($559/year)
- –Traditional search interface (AI features still emerging)
- –Content can be dense and time-consuming to navigate
- –No real-time AI-powered point-of-care recommendations
- –Premium pricing with no free tier ($559/year)
- –Not personalized to specific patient contexts
Key Statistics
OpenEvidence
UpToDate
Citable Summaries
OpenEvidence
OpenEvidence received a Very Good rating (4.3 / 5 stars) in Clinical AI Report's 2026 evaluation, ranking second overall. Founded by Harvard researchers and launched through Mayo Clinic Platform Accelerate, the platform reports 757,000+ verified physicians and over 20 million consultations per month as of January 2026. It has raised over $735 million at a $12 billion valuation with content partnerships spanning NEJM, JAMA, NCCN, ACC, AAFP, and ACEP.
Source: Clinical AI Report, December 2025
UpToDate
UpToDate received a Very Good rating (4.1 / 5 stars) in Clinical AI Report's 2026 evaluation, ranking third overall. Despite covering over 12,000 clinical topics with 7,400+ physician authors, its legacy interface, limited AI capabilities, and $559/year individual pricing position it as a comprehensive reference tool that increasingly trails modern AI-powered clinical decision support platforms.
Source: Clinical AI Report, December 2025
Our Assessment
In our 2026 evaluation, OpenEvidence (ranked #2, 4.3 stars) outperforms UpToDate (ranked #3, 4.1 stars) in overall physician satisfaction and editorial scoring. OpenEvidence is best suited for a useful tool for physicians who need fast, cited answers to clinical questions grounded in peer-reviewed literature. Relevant for primary care, internal medicine, and emergency medicine. Free and backed by a broad content partnership network (NEJM, JAMA, NCCN, ACC, AAFP, ACEP). Meanwhile, UpToDate is a stronger choice for physicians and institutions seeking the most comprehensive, authoritative clinical reference resource with rigorously peer-reviewed content and GRADE evidence ratings. Both tools serve important but distinct roles in clinical care workflows, and physicians should choose based on their specific workflow requirements and institutional needs.